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Abstract
Nerve guidance conduits (NGCs) have emerged from recent advances within tissue engineering as a promising
alternative to autografts for peripheral nerve repair. NGCs are tubular structures with engineered biomaterials, which
guide axonal regeneration from the injured proximal nerve to the distal stump. NGC design can synergistically
combine multiple properties to enhance proliferation of stem and neuronal cells, improve nerve migration,
attenuate inflammation and reduce scar tissue formation. The aim of most laboratories fabricating NGCs is the
development of an automated process that incorporates patient-specific features and complex tissue blueprints
(e.g. neurovascular conduit) that serve as the basis for more complicated muscular and skin grafts. One of the major
limitations for tissue engineering is lack of guidance for generating tissue blueprints and the absence of
streamlined manufacturing processes. With the rapid expansion of machine intelligence, high dimensional image
analysis, and computational scaffold design, optimized tissue templates for 3D bioprinting (3DBP) are feasible. In
this review, we examine the translational challenges to peripheral nerve regeneration and where machine
intelligence can innovate bottlenecks in neural tissue engineering.
Keywords: Bioprinting, Data science, Tissue engineering, Computer vision, Nerve regeneration, Machine learning,
Artificial intelligence
Background—critical challenges in (re)innervation
Peripheral nerve injuries (PNI) are a common source of
disability that originate from traumatic, nontraumatic,
and iatrogenic causes [1–3]. Advancements made in tis-
sue engineering have led to the emergence of nerve
guidance conduits (NGC) that offer a promising replace-
ment for autografts [4]. Nerve guides are tubular bios-
tructures designed to house growth factors and neural
progenitor stem cells in a microenvironment conducive
for nerve regeneration. Many challenges exist in clinical
research to produce a conduit that meets or exceeds the
performance of autografts for treatment of short and
long gap nerve injuries. From a clinical research stand-
point, Sun et al. have documented a recent rise in ran-
domized control trials (RCTs) for peripheral nerve
repair but suboptimal quality of systematic reviews on
the subject [5]. They found the number of annual sys-
tematic reviews increased from 2004 to 2015 but median
scores rated fair in quality throughout this period [5].
Establishing NGC superiority over traditional treatments
will be a major challenge considering evidence-based
medicine (EBM) faces similar problems determining the
effectiveness of standard peripheral nerve repair [5, 6].
In particular, PNI categories cover a large domain that
includes nerve types (sensory, motor, both), mechanisms
(stretch, crush, percussion, laceration), anatomical
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regions (plexuses, nerve root, extremities), and anatom-
ical variants. Tissue engineers need to consider these
standards among others when designing nerve conduits
and scaffolds. This makes a transdisciplinary approach
attractive since experts from the fields of engineering,
physics, computer science, and medicine can blend their
faculties into a comprehensive biomanufacturing process
and product.
Nerve conduits provide a customizable solution for
both repair options by tailoring conduit features to
patient-specific injuries to enhance the repair of acute or
chronic injuries. Narayan et al. performed a systematic
review and meta-analysis of three randomized control
trials (RCTs) comparing conduits with conventional
nerve repair [7]. Three RCTs showed conduits were sig-
nificantly more effective compared to standard end-to-
end suture repair for short gap (< 10 mm) sensory nerve
injuries [7]. More studies are required to assess the ef-
fectiveness of conduits for motor and mixed nerves in-
cluding cranial nerves and complex nerve plexuses.
From a tissue engineering perspective, many novel fea-
tures have been utilized for peripheral nerve regener-
ation [8], specifically, neurotrophic factors and
anisotropic gradients, electrical stimulation [9], pluripo-
tent stem cell derived progenitor cells [10, 11], 3DBP
[12], immuobioengineering [13], nerve differentiation
strategies, simultaneous vascularization, design
customization [14], and gene therapy [15–17]. Here we
briefly reviewed to identify points of intersection be-
tween tissue engineering and machine intelligence with
a particular concentration on peripheral nerve regener-
ation. We utilize these examples along with current en-
gineering challenges encountered in peripheral nerve
regeneration to postulate where machine intelligence
can complement biofabrication in product performance,
additive manufacturing (AM) processes, and medical
regulatory compliance.
Classification of nerve injuries
In 1951, the Sunderland classification system became
(Fig. 1) the preferred PNI grading system, since it makes
better clinical prognostications and directs appropriate
therapy [19–21]. Sunderland identified five injury grades
where Grade I is the least severe and Grade 5 is the
most severe. Grade I is neuropraxia caused by focal de-
myelination and presents with short term paralysis. Neu-
ropraxia is a reversible injury that does not require
intervention. Whereas, Grade II corresponds to axo-
notmesis denoting axonal destruction with intact epi-
neurium [22, 23]. Axonotmesis is an irreversible injury
to the axon usually caused by crush, stretch or percus-
sive events. Grade III PNI results in the loss of endo-
neurium but intact perineurium leading to misguided
axonal regeneration and making spontaneous recovery
less probable [24, 25]. This injury is referred to as the
least severe form of neurotmesis. Grade III injuries re-
cover partially and do not require surgical repair. Grades
IV and V represent PNIs requiring surgical intervention
to restore function. Grade IV are the result of damage to
the endoneurium and perineurium. While, Grade V is
loss of all three layers ensheathing the nerve [22, 25]..
(Reproduced with permission from reference 19.
Copyright Elsevier [18])
Current strategies of NGC Design in Tissue Engineering
Here we categorize current strategies of NGC design
with integrating: 1) biological modulation 2) engineering
approaches and 3) surgical intervention.
Biological modulation
a. Gene delivery
Gene therapy has developed novel therapeutics to treat
peripheral nerve insults [26]. Gene therapeutic strategies
extend to but are not limited to eliminating toxic pro-
teins at injured sites, activating regenerative phenotypes
in chronic nerve injuries, increasing expression of thera-
peutic signals in cellular components in nerve regener-
ation, increasing sensitivity to cell to cell
communication, and programming stem cells to differ-
entiate in a specific manner [26]. Novel studies have im-
proved transduction efficiency and genetic transfer using
both non-viral and adenovirus methods [27–29]. Adeno-
associated viral (AAV) vectors have become a popular
method for gene delivery in peripheral nerves because of
their low risk for immunogenicity, mutagenesis, and
higher titers [30–32]. Different viral serotypes display
unique transduction profiles and perform better in spe-
cific neurons [33, 34]. For example, AAV5 is the pre-
ferred serotype for treating sensory neurons in rat
models [34]. AAV vectors have been effective tools for
identifying the effects of particular genes on regeneration
and survival of motor and sensory neurons [35–38].
Gene therapy can target Schwann cells whose regen-
erative properties fade after chronic states of denervation
[29]. Gene therapy studies have typically used lentiviral
vectors to enhance regenerative phenotypes of Schwann
cells seeded in nerve guides [39–43]. Gene therapy tar-
gets neurotrophic factors (NTF) genes to increase their
expression, stimulate axon regeneration, and promote
directional growth towards targets [39, 44, 45]. One
drawback to this method is overexpression of NTFs and
trapping of budding axons [43, 46]. These findings re-
quire future research to optimize the concentration and
temporal gene expression to maximize therapeutic po-
tential. Further research is required to develop vector
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modalities, improve vector safety, and identify gene
targets.
b. Growth factor stimulation
Growth factor (GF) for stimulation of peripheral nerve
regeneration is not a new concept. NTFs are placed in
the lumen of nerve guides to promote regeneration. Ef-
fective factors for nerve regeneration include nerve
growth factor (NGF), neurotrophin-4/5, neurotrophin-3
(NT-3), glial cell derived neurotrophic factor (GDNF),
ciliary neurotrophic factor (CNTF), fibroblast growth
factor (FGF), interleukin-6 (IL-6), and brain derived
neurotrophic factor (BDNF) [47–51]. NTFs use path-
finding gradients to stimulate or inhibit axonal out-
growth, [52, 53] direct axonal elongation [54], promote
stem cell differentiation [55] and recruitment [56], and
program Schwann cells [57]. Several design strategies
have been employed by directly conjugating NTFs to
conduit walls [58] or stimulating neural cells to secrete
NTFs within the lumen [59, 60]. Another GF strategy ar-
ranges NTFs, extracellular matrix (ECM) proteins, and
stem cells in a longitudinal gradient to orient regenerat-
ing axons towards the distal stump. NGCs are beginning
Fig. 1 Sunderland Classification of Nerve Injuries [18]
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to incorporate anisotropic gradients into their designs,
which mimic physiological conditions for nerve injury
repairs [49, 52, 61]. Several problems arise when working
with NTFs including: determining optimal NTF dosing,
NTF mixtures, biological gradients, and release kinetics
confining their use to experimental research [62–64].
The uncertainty surrounding GF variables, GF limited
stability (short half-life), and regenerative interference at
high dosages limit translation into surgical products
[65]. Finding strategies to address these challenges
would make 3D bio-printed products more effective,
feasible, and predictable for clinical use [66].
c. Autologous and allogeneic stem cells
Stem cells mimic physiological repair responses known
as Büngner bands when arranged in NGC microarchitec-
ture [67], thus incorporating stem cells into NGC design
is a promising strategy to promote nerve regeneration.
Autologous stem cells are difficult to harvest and prolif-
erate in a time-sensitive manner making non-autologous
sources more attractive options for nerve lacerations [68,
69]. However, patient-derived stem cells have the advan-
tages in that they do not provoke an immune response,
which avoids expensive phase I and II toxicity and bio-
compatibility tests and lowers the regulatory burden for
advanced therapy medicinal products (Regulation (EC)
1394/2007). Autologous cells would work well for de-
layed repairs in blunt trauma cases or with poor recov-
ery following a period of observation. The time waiting
for surgery would allow for adequate cell harvest and
maturation time for eventual conduit seeding. Popular
autologous cells include skin-derived neural precursors,
bone marrow-derived stem cells (BMSCs), nerve stem
cells (NSCs), adipose-derived stem cells (ADSCs), and
pluripotent stem cells (PSCs) [70, 71]. Stem cells can be
selected for specific phenotypes having a predilection for
motor or sensory differentiation [72]. Thus, seeding lu-
mens with specific cell phenotypes in conduit lumens
can generate motor and sensory tracts in mixed con-
duits. Each stem cell group has its advantages and draw-
backs. BMSCs have been proven as effective as
autografts in animal models for nerve regeneration [73].
However, harvesting these cells is uncomfortable with
poor differentiation and proliferation [74]. NSCs are
even more complex to harvest and have an inclination
toward neuroblastoma formation [75].
Several studies have explored the utility of allogeneic
stem cells, which may provide a solution for immediate
nerve repairs with conduits [76–78]. One study seeded a
conduit with embryonic stem cells (ESCs) to bridge a
nerve gap spanning 10 mm. Immunostaining following
regeneration revealed properly differentiated myelinating
cells and a uniform connection extending from the
proximal to distal stumps [76]. ESC-derived motor neu-
rons injected into tibial nerves of mice resulted in a re-
duction in muscular atrophy [77]. Umbilical cord
mesenchymal stromal cells (UC-MSCs) and umbilical
derived cells with stem cell properties (UC-SCs) have
been used in conduits to regenerate an 8 mm nerve gap
in rats [79].
d. Immunomodulation.
The quality and rate of nerve regeneration is greatly
improved when there is a minimal amount of scar tissue
in the nerve gap. Peripheral nerve surgeons often per-
form neurolysis to free up nerves from scar tissue to
promote regeneration [80]. External neurolysis treats
scars forming on the outside of the nerve epineurium,
while internal neurolysis removes intrafascicular scars.
Both treatments attempt to prevent axonal constriction
to allow nerve regeneration. Over-aggressive scar exci-
sion can impair the blood supply to fascicles and thus
counteract its benefits. Modulating the inflammatory
process to prevent scar formation for peripheral nerve
repair would enhance nerve regeneration without com-
promising existing structures.
The key for PNS regeneration is based on myelin deb-
ris clearance. In injured CNS, myelin debris can persist
from months to even years after injury and it creates a
major roadblock for brain and spinal cord repair [81]. In
the PNS, however, inflammatory cells such as monocytes
and macrophages quickly arrive at the damaged site to
begin myelin debris clearance by phagocytosis and/or
autophagy which results in quicker nerve regeneration
[13]. Moreover, the lesser known tissue resident glial
cells, Schwann cells and perineural cells, also contribute
to the myelin debris removal [13]. Lutz et al. showed
that myelin clearance was dependent on TAM (Tyro3,
Ax1, Mer) receptor mediated phagocytosis in a mouse
model [81]. Even though past studies have uncovered
several cell types that contribute to this recovery
process, the recruitment of these cell types into the dam-
aged site remained elusive.
After PNS injury, neurons quickly change their activ-
ities to promote a secretory type. Monocyte descendants,
especially macrophages, quickly enter the injured site to
remove inhibitory degrees and enable new exons to
sprout into the degenerated nerves directed by the band
of Büngner [82]. It has been known that specific macro-
phage types (e.g. M1, M2) can drive either the healing or
inflammation response [82]. While inflammatory sub-
types secrete inflammatory cytokines, M2a and M2b
macrophages secrete anti-inflammatory cytokines to en-
courage angiogenesis and matrix forming [82].
Besides M2 macrophages, T cells and monocytes with
certain receptors also play a role in anti-inflammatory
PNS healing. Studies have shown that certain chemo-
kines can induce nerve repair by increasing pro healing
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inflammatory cells [83]. In particular, IL-4 has been
shown to have a CD4+ TH2 dependent functional tissue
restoration depending on the mTOR/Rictor-dependent
pathway [83]. Furthermore, monocytes with high CD43,
high CX3CR1 and low CCR2 have known to induce
PNS healing by enhancing debris clearing [81]. Mokrram
et al. reported that fractalkine increases macrophages ac-
tivity by activating CXCR1 receptor, and increases the
ratio of pro-healing macrophages to total number of
macrophages [82]. In fact, fractalkine treated scaffolds
outperformed IL-4 treated scaffolds in PNS healing
using a mouse model [82]. As such, integrating chemo-
kines such as fractalkine or IL4 into peripheral graft
have the potential to enhance PNS healing in animal
models [81, 83].
Interestingly, antibody produced from B cells also
plays a role in myelin debris clearance. Vargas et al. has
showed that natural antibody accumulates at PNS dam-
age sites, and that B cell- deficient mice exhibit impaired
axon regeneration after sciatic nerve damage [84]. This
suggests that the humoral immune system induced
phagocytosis also plays a role in nerve regeneration.
However, a more recent study showed that adaptive im-
munodeficiency Rag −/− had an increase in axonal de-
generation and increased healing due to increase in
macrophages to compensate for the reduced T and B
cells [85]. Given the contrasting and possibly conflicting
results between humoral immune system and PNS heal-
ing, more studies are needed to confirm their
relationship.
One part of PNS regeneration that is overlooked is im-
mune cell-to-cell communication. One method that im-
mune cells communicate is by releasing exosomal
microRNA (miRNA) to enhance or reduce PNS healing.
For example, miR-340 from macrophages is shown to
boost Schwann cell debris clearance [86]. While in a rat
model, miR-223 from M2 macrophages have been
shown to inhibit cell migration and proliferation by
downregulating the expression level of NGF and laminin
[87]. Therefore, there is a potential to use exosome to
deliver miRNA to promote PNS healing.
Overall, humoral, adaptive and innate immune systems
play a significant role in PNS regeneration. By manipu-
lating different aspects of the immune systems through
cytokines, chemokines or miRNA, it is possible to en-
hance PNS regeneration along the nerve conduit.
Engineering approaches
a. Engineered microenvironments
Engineered biomaterials used to manufacture NGCs
need to promote proper nerve growth down the graft
and into the distal nerve segment, while avoiding
incitement of inflammatory host responses. This is ac-
complished through the selection of cell-interactive bio-
materials as the mainstay of the grafts. Natural
biomaterials found in the tissues do not elicit inflamma-
tory responses. Structural molecules including glycopro-
teins, collagen, and polysaccharides help maintain tissue
shape and function [88]. These biomacromolecules have
shown promise in producing results similar to autolo-
gous nerve grafts in animal models, but more research is
needed to determine if this will prove true in humans
[69]. Biomaterials proven favorable for vascular and
neural tissue regeneration with in vitro studies may sur-
prisingly impair regeneration during in vivo studies [89],
which increases the difficulty of selecting materials that
translate from in vivo studies to animal models and fi-
nally human trials.
Biodegradable polymers at particular rates will be ad-
vantageous for effective nerve regeneration in native tis-
sue. Grafts that are more porous have been shown to
degrade at a slower rate than more dense grafts but with
a faster surface degradation [90]. Longer degradation
times may reduce the ability of the nerve to regenerate.
On the other hand, grafts need to allow diffusion of oxy-
gen, water, and nutrients to promote nerve growth [91,
92]. This requires research into the porous nature of
grafts to optimize the compromise between permeability
and degradation. Failure to strike this balance may inter-
fere with the nerve regeneration process such as allow-
ing increased infiltration of fibroblasts in more porous
conduits [93].
Nerve axons also need to penetrate the substance or
lengthen along microchannels within the NGCs, which
means the material has to maintain its structure. It has
been shown that variations in microstructure such as
inner surface-area-to-volume ratio can differentially
affect the growth of axons [94]. A recent study explored
single lumen and multi lumen NGC designs. Single
lumen has shown benefits for shorter (< 30 mm) lesions,
while multi-lumen designs show no improvement in
outcomes when compared with single lumen NGCs [95].
This may have occurred due to reduced permeability,
flexibility, or just variations in the materials used in the
actual NGCs.
Another consideration for NGC construction is manu-
facturing methods. Many processes exist for generating
a variety of heterogenous mediums making it a signifi-
cant decision in NGC design. Electrospinning, porogen
leaching, and rapid prototyping are just a few of the
methods used to create NGCs [38, 51]. Rapid prototyp-
ing is a less established method but has enhanced the re-
producibility of computer-driven graft designs but is
limited by its high costs [90]. Biomaterials used for
NGCs also need to be compatible with the chosen tech-
nique. For example, certain fabrication techniques have
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made chitosan deleterious to nerve regeneration by in-
ducing massive foreign body reactions after suturing to
the nerve stumps [96]. While the effectiveness of the
material will likely have more of a determination on
what method is chosen, factors cost, availability, and
large-scale production will influence feasibility for
healthcare systems implementing this technology.
b. Electrical stimulation and conductive scaffolds
Electrical stimulation (ES) of transected nerves has
emerged as an effective therapy to improve axonal out-
growth and reinnervation [97]. Several studies have re-
ported accelerated axonal extension and increased
twitch force following ES [98, 99]. More recent reports
have provided further insights into the mechanisms
underlying ES and nerve regeneration [100]. Effective ES
relies on a low-frequency stimulus (20 Hz) within an
hour of primary surgical repair of nerve transections
[100]. A RCT using brief low-frequency ES resulted in
early and complete reinnervation following carpal tunnel
release surgery [101].
Tissue engineers have leveraged the effectiveness of
ES to create conductive biomaterials for constructing
NGCs [95]. Synthetic conductive biomaterials propa-
gate electrical signals to stimulate regenerating axons
[102]. Polypyrrole (PPy) is a conductive polymer uti-
lized in recent bioprinted conduit designs. One major
limitation to PPy is its poor biodegradability, solubil-
ity, and flexibility [103]. Yet, animal studies showed
PPy sustained sciatic nerve regeneration [102–104]
resulting in functional recovery approximating autolo-
gous grafts [104]. Several research groups have shown
that PPy scaffolds can orient neurites and increase
their number and median length [104–106]. Another
promising conductive biomaterial is carbon nanotubes
(CNTs) [107, 108]. CNTs or graphene-based nerve
conduits integrate with native tissue and do not elicit
an immune response after implantation [107]. Nano-
fabrication is opening up the possibility for more ef-
fective electrodes to pair with NGCs [109]. The
combination of electrodes and NGCs is referred to as
peripheral nerve interface devices that further en-
hance signal propagation for regenerating nerves
[110]. Peripheral nerve devices are produced when
NGCs ensheath metal electrodes comprised of nano-
particles during the 3D printing process [111, 112].
Advanced ES methods are required in conduit design
to include compact electrodes that effectively inte-
grate with more biodegradable conductive conduit
materials to improve performance. Synchronizing
electrical stimulation with biomaterial porosity and
degradation accelerates axonal regeneration, but at
the risk of exaggerated sprouting leading to
entrapment. Synchronizing these conduit features re-
mains a challenge for clinical translation.
c. Customizable and personalized NGCs
A major limitation in advanced NGC biofabrication is
the ability to fabricate complex architectures, adjustable
biomaterials, and customizable morphologies to accom-
modate different nerves and different patients [113]. Bra-
chial plexus surgery has been overall disappointing in
large part due to the inadequacy of nerve grafts to match
complex anatomy and the proximity of the injury. Stand-
ard treatment calls for an ulnar nerve or sural nerve trans-
fer for intrafascicular graft repair [114, 115]. Recently,
systematic analyses propose using a dual nerve transfer for
restoring shoulder abduction compared to single nerve
transfer, nerve graft, or combined nerve graft and transfer
[114, 115]. Developing NGCs that can adapt to the patient
variations in injured nerves, local vasculature, and fascicu-
lar architecture would provide an edge to current stan-
dards of treatments for these complex injuries. Surgeons
typically delay intervention by three to six months to as-
sess for spontaneous recovery, which provides ample time
for constructing customized conduits. One study used
extrusion-based 3D printing to develop a personalized
NGCs reflecting patient-specific macrostructural nerve
morphology (shape, diameter, length) and biomimetic
microchannels [67]. The downside to extrusion-based 3D
printing is its low printing resolution, slower print speeds,
and artifacts [116, 117]. Addressing these limitations is ne-
cessary to scale biomanufacturing operations to optimize
NGC performance and meet the volume of health systems
for acute and chronic nerve repairs. Researchers can com-
bine the imaging information of computer tomography
(CT), magnetic resonance imaging (MRI), and computer-
aided design (CAD) for macrostructural dimensions and
geometries, while 3D reconstructions of nerve histology
slices provide the microstructural pattern. Current treat-
ment guidelines utilize magnetic resonance neurography
(MRN) to locate nerve injuries and characterize the extent
of injury. Tissue engineers can process these scans for pre-
paring a blueprint to fabricate NGCs to determine nerve
diameter, gap length, and nerve shape. Generating
patient-specific fascicular architecture for NGCs may re-
quire sampling complete nerve injuries during exploration
if primary repair without tension is not possible [118,
119]. This may be feasible in the circumstances of certain
nerve transections or following nerve tumor resections. A
more promising solution would be the arrival of high-
powered (7 T) MRI scans that can visualize fascicular pat-
terns within nerves [120]. Fascicle matching will require
coordinating clinical management and advanced bioima-
ging and tissue processing tools to generate microchannel
facsimiles of patient tissue [116, 118].
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Matching implant and host tissue properties is import-
ant for NGCs to reduce the risk of compressive or tear-
ing of regenerating nerves [119–121]. Zhu et al.
proposed a digital light processing (DLP)-based rapid
continuous 3D-printing method to fabricate customized
NGCs with material properties corresponding to the in-
jured tissue [113]. 3D bio-printer specifications will need
to precisely control mechanical properties of 3D prints
to match the varying viscoelasticity of peripheral nerve
tissue [122–124]. Another study incorporated multiple
design elements (geometry, NTFs, anisotropic gradients)
effective in nerve regeneration within a single conduit
[125]. Personalized conduits will need to build on these
recent advancements by incorporating conductive mate-
rials, programmed stem cells, nerve differentiation, and
vascularization into a single design. Combining these
features will serve to increase nerve gap regeneration
size and improve functional recovery.
Surgical intervention
a. Vascularization
Peripheral nerves receive their blood supply from
small vessels entering the epineurium (intrinsic) from
neighboring feeding arteries (extrinsic). The intrinsic
blood supply is important for regeneration because it al-
lows large molecules, growth factors, immune cells to
enter the endoneurial space after the blood-nerve barrier
breaks during Wallerian degeneration [126]. Vascularity
of nerve grafts has become a greater focus of nerve graft
research [62]. The importance of creating grafts with
vascular networks is the need to increase the effective-
ness of longer graft segments. It is thought that one of
the limiting factors is the ability to supply enough nutri-
ents and oxygen to facilitate axon growth. Research has
shown that vascular networks within NGCs can be en-
hanced in the early post-transplantation period by in-
cluding vascular bundles in the graphs [127].
Consequently, increased vascularity of nerve grafts has
been demonstrated to improve overall nerve regener-
ation and axonal elongation [128, 129]. They have also
been shown to significantly increase nerve diameter,
neuron number and electrical conduction in comparison
with non-vascular silicon grafts [62]. Vasculature net-
works enhance nerve repair by transporting oxygen and
nutrients, sustaining axon survival, and directing axonal
extension [62, 130]. Activating these cellular processes is
crucial in long-standing nerve injuries where reduced
perfusion creates resistant microenvironments for axio-
genesis [131]. Surgeons anastomose nerve graft vessels
to recipient vessels to maintain perfusion and prevent
necrosis during nerve repair [132]. Vascularization is an
attractive graft feature for chronic injuries or delayed
surgical repairs characterized by low vascularity because
these grafts could accelerate the rate of axonal elong-
ation [133, 134]. Synthetic nerve graft performance has
also been found to improve when paired with local vas-
culature [135–137]. However, studies suggest that while
these vascularized grafts can improve reinnervation over
non-vascularized grafts, they have yet to equal non-
vascularized graft performance [135]. A major objective
in surgical nerve repair is avoiding damage to extrinsic
vascular supply feeding intrinsic vascular networks and
collateral circulation because it can result in ischemia,
nerve death, and scar formation [138]. Providing sur-
geons with a vascularized graft would allow them to per-
fuse the injured nerve and improve the success rates of
nerve conduits. In the future, the combination of vascu-
larized nerve scaffolds can provide the foundation for
complex nerve tissues e.g. skin grafts or neuromuscular
grafts.
b. Nerve differentiation
One of the main shortcomings of nerve regeneration
following PNI is the inability to recover normal motor
and sensory components [51]. Mixed nerve injury re-
pairs utilize nerve transfers from sensory nerves such as
the sural nerve. For example, nerve grafts using the sen-
sory sural nerve display inferior regeneration when used
for mixed or motor nerves [139]. Nerve regeneration
without precision in motor and sensory differentiation,
guidance, or target reinnervation is a major difficulty for
current treatment options [51]. Brushart observed that
mixed nerves display preferential motor reinnervation
(PMR) where regenerating motoneurons reaches their
appropriate motor pathway and target when compared
to sensory pathways [140]. In other words, when moto-
neurons are provided equal access to motor and sensory
pathways motoneurons favor the motor pathways. The
components generating this biological preference in-
clude pathway-specific support cell phenotypes [72],
NTF composition [141], and both pathway-specific ECM
proteins and architecture for sensory and motor trajec-
tories [139].
The concept of modality-specific Schwann cell pheno-
types originated from PMR research, which found that
distinct motor and sensory Schwann cells existed for in-
dividual pathways [141]. Researchers have found differ-
ential NTF expression for motor and sensory Schwann
cells [72, 142]. Microarrays has revealed that pleiotro-
phin (PTN) is specific for Schwann cells in motor path-
ways, which has neurotropic and neurotrophic effects
[143]. PTN or heparin binding neurotrophic factor
expressed in Schwann cells, endothelial cells, and macro-
phages promotes elongation of motoneurons [144]. Con-
versely, the same studies found sensory axons grew away
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from PTN gradients. Another study found sensory neur-
ites have the propensity to grow towards elevated levels
of BDNF and NGF [145]. Misdirection of motor and
sensory pathways is a persistent problem for nerve re-
generation and repairing mixed nerve injuries [141]. Be-
sides growth factor composition and Schwann cell
phenotype, Madison et al. found the most important de-
terminants for peripheral nerve regeneration was muscle
contraction in the distal stump along with Schwann cell
density in the distal stump [146]. The development of
NGCs with the capacity for sensory, motor, or mixed re-
generation would provide a crucial advantage over
current treatment options for mixed nerve injuries [67].
Challenges to incorporate multiple biological and
engineering factors for surgical intervention
The first section identified the key components and
strategies used to regenerate peripheral nerves. Tissue
engineering deploys the biotechnology toolkit to embed
biological components into engineered structures. Har-
monizing biological components (genotypes, stem cells,
growth factors, immunomodulation, vascularity, etc.)
and strategies (gene-editing, cell culturing, cell-signaling,
biomaterials, bioprinting) with native conditions (injury
type, nerve type, nerve dimensions, gap length, anatomy,
and host-tissue receptivity) is a major challenge for sys-
tematizing the biofabrication process. Several constraints
impede progress in this area, namely, current character-
izations and approaches to regeneration, cost of entry
into biofabrication and biotechnology, and biomedical
regulations.
Current surgical management for PNIs has several
drawbacks. Nerve grafts such as allografts and xenografts
require immunosuppression and expose the patient to
risks of cross contamination, immune rejection, and in-
fections passed from the donor [147–149]. Immunosup-
pression also makes the patient more susceptible to
infections postoperatively. AvanceⓇ is one such FDA
approved allograft that has been decellularized and proc-
essed for implantation. AvanceⓇ has been shown to be
effective for nerve repairs spanning 1-2 cm, and actually
outperformed available second-generation conduits
[150]. However, Avance does not yield the regenerative
effects produced by isografts. Autografts require sacri-
ficing native nervous tissue that usually result in sensory
deficits and are often insufficient for reasons pertaining
to nerve size, length, nerve complexity (plexuses), nerve
type (motor, mixed), etc. [151]. First- and second-
generation NGCs have been developed and approved by
the FDA for nerve repair [152]. First-generation NGCs
are generally preferred for long gap repairs exceeding 4
cm [152]. Their lumens lack supportive elements (e.g.
cells, proteins, growth factors, blood products) that
newer synthetic conduits incorporate. One such example
is the SaluTunnel™ made of nonresorbable PVA hydro-
gel. SaluTunnel is not validated by clinical studies mak-
ing their clinical use uncommon [153]. Second-
generation nerve conduits are made from resorbable ma-
terial with greater biocompatibility (e.g. type I collagen,
poly-DL-lactive-co-caprolactone (PLCL), polyglycolic
acid (PGA)). Similar to first-generation nerve conduits,
second-generation sconduits have empty lumens without
supportive elements. Neuragen™ Nerve Guide is an FDA
approved resorbable implant derived from bovine tissue.
It is a porous Type 1 collagen tube designed to provide a
protective environment for nerve repair. Neuragen pro-
vides an adequate solution for repair in nerve gap
lengths between 1 and 2 cm based on several studies
[154, 155]. Overall, deficiencies in nerve grafts and first-
and second-generation NGC design make tissue engi-
neered NGCs more attractive for treatment of long gap
PNIs and enhancing short gap repairs.
Tissue engineering and biomanufacturing is in its in-
fancy and presently lacks standardized facilities and op-
erations for scaling within the medical industry. Internal
constraints stem from a deficiency of systems in tissue
engineering leading to disjointed research disciplines
(genetics, cell biology, bioengineering, medical experts).
Current research largely identifies components of bio-
logical structures and attempts to include them into de-
signs intended regenerate tissue. This approach ignores
the scalar hierarchy of biological form and function
where organization and timing of component interac-
tions at each level (genes, proteins, cells, tissue) is just as
important as the components themselves for higher-
order functions to emerge. To combat the complexity
and imprecision of biofabrication, we propose machine
intelligence be employed at each stage of the NGC bio-
manufacturing process. The following section provides
examples of machine intelligence augmenting tissue en-
gineering from literature with an emphasis on peripheral
nerve regeneration. These areas address internal con-
straints (biomaterial design, stem cell editing, graft per-
formance, bioprinting) and external constraints such as
the financial barriers (equipment, personnel, facilities)
and regulations to biomanufacturing. In an effort to in-
tegrate tissue engineering with machine intelligence, we
reviewed the status quo of ML and neural networks for
NGC design and PNS regeneration in the following
sections.
Machine intelligence approaches to tissue engineering
a. Machine intelligence and adaptation to nerve
regeneration
With the advancement of computer hardware and the
emerging of technologies in deep learning, Artificial
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Intelligence (AI) has become one of the fastest growing
technical fields and has been adopted across many appli-
cation domains including healthcare. AI based technolo-
gies have the potential to transform the healthcare and
the number of AI based solutions for healthcare ap-
proved by U.S. Food and Drug Admission had increased
to 26 by July 2019 [156].
Deep learning as a subset of machine learning (ML)
which is in turn a subset of Artificial Intelligence (AI),
has become so popular and led to the AI explosion in
the last five years [157–159]. Artificial intelligence (AI)
can be defined as the science and engineering of making
computers behave in a manner like humans. AI is a
multidisciplinary topic in data science, which merges
computer science, cognitive science, and mathematics to
develop processes, algorithms, and systems to achieve
human intelligence by machines. Another topic closely
associated with AI is ML, it is an approach to achieve AI
by parsing data, learning from that data and then apply-
ing what they have learned to make an informed deci-
sion. With ML, machines are trained using large amount
of data and algorithms such as Artificial Neural Net-
works (ANN) to extract and represent knowledge from
the data. ANN has been around since early 1990s, but in
a limited fashion (e.g. three layers—input, hidden, out-
put) due to the limitation of computing power. With the
emerging of powerful computer chips, microprocessors
and graphics processing units (GPU), Convolutional
Neural Networks (CNN) have emerged. CNNs can be
stacked over 100 layers deep. This is the origin of Deep
Learning. It is a more advanced technique for ML imple-
mentation. With a multitude of layers, the deep neural
networks can be used to tackle complex data and enable
many applications of DL in various domains.
Deep Learning has now become the main driver for
many new applications. It can be used for object detec-
tion, classification and regression. Some state-of-the-art
deep learning models for the object detection include: R-
CNN [160], Fast R-CNN [161, 162], Faster R-CNN [162]
proposed by Ross Girshick et al. at UC Berkeley, and
Yolo [163] presented by Joseph Redmon et al. from
Facebook AI Research; the state-of-the-art deep learning
models for the classification include AlexNet designed
by Alex Krizhevsky et al., [164] and VGGNet invented
by Visual Geometry Group from University of Oxford
[165], ResNet proposed by Kaiming He et al. at Micro-
soft Research [166], and DenseNet designed by Gao
Huang et al. [167]. For the regression, the final layer of
the above models for the classification can be replaced
with a fully connected regression layer with linear or sig-
moid activations. Some traditional regression methods
may also be useful for solving problems in NGC design,
such as ordinary least square and gradient descent based
linear regression, and Gauss-Newton, Gradient descent
and Levenberg-Marquardt algorithms based nonlinear
regression. Recent work on Bayesian neural networks
shows the feasibility of estimating uncertainty due to the
lack of training data. This is important for medical appli-
cations because of the safety requirements. Research
demonstrates that some new network architectures
generalize well even with less training data, such as cap-
sule networks [168].
To achieve the promises of peripheral nerve repair
using NGC and digitally translate a blueprint of design
to regeneration [169, 170], it will require harnessing big
data quantitatively and predictively in the lab and clinic
for every aspect of the regeneration. These include but
are not limited to AI-based engineering design tools for
NGC. The emergence of deep learning technology can
lend itself to many aspects in biofabrication including
regulatory compliance, stem cell priming and selection,
growth factor concentrations, favorable biomaterial
properties, regenerating multiple tissues in a single scaf-
fold, decoupling multiple characteristics for a regenera-
tive outcome, selecting patient-specific NGC features
based on parenchymal composition, nerve types, modes
of injury, genetic variations, enhance device testing, and
improving AM operations. We will explore where
current research has merged machine intelligence and
nerve regeneration and where machine intelligence and
tissue engineering can interface to accelerate innovation.
To demonstrate how to use ML for the regeneration,
we selected a few cases which provide examples of using
ML for improving conduit performance via modification
of biomaterial properties, growth factor considerations,
or improving stem cell cultures through gene editing.
We will start with an example illustrating how to use
our proposed ML method for personalized, AM of nerve
guidance conduit.
b. ML for optimal NGC design for AM
Poly (glyerol sebacate) (PGS) is an emerging promising
flexible biomaterial for nerve repair. The photocurable
of PGS can be used for light-based AM of NGCs [171,
172]. Chemical and mechanical characterization results
showed that PGS became stiffer with increasing degrees
of methacrylation, and its surface became more hydro-
phobic and the degradation rate decreased. The mechan-
ical properties in the range of soft tissues, and the
degradation from weeks to months can be tuned to ac-
commodate both fast and slow regenerating tissues. De-
pending on the length of the nerve gap of individual
patients, the material can be tuned to degrade at an ac-
ceptable rate which is long enough for regeneration and
maturation, yet quick enough to minimize long-term in-
flammation. Conduit size is also an important factor for
regeneration and balancing the internal diameter to
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allow the injured nerve to expand without compression
while preventing ingress of surrounding tissues.
For the optimal design and 3DBP, we need to predict
the percentage methacrylation P required for the 3DBP
of an NGC for a particular patient based on the nerve
gap of the patient g, the time required for the nerve re-
generation and maturation t with concurrent degrad-
ation of the NGC, the diameter of the conduit d, and the
thickness of the conduit w, as shown in the function
below.
P¼ f g; t; d;wð Þ
Because the relationship among the percentage metha-
crylation and other factors expressed in the above func-
tion can be highly non-linear, an empirical or
phenomenological constitutive equation is most often
used to model such a relationship and is fit using multi-
variate non-linear regression. However, the regression is
usually restricted to certain conditions. To make the
model generalize well and adapt properly to new, previ-
ously unseen data, ML can be used to model the highly
non-linear relationship and predict the percentage
methacrylation using the following parameters as input:
the nerve gap of individual patients, the time required
for the nerve regeneration and the conduit dimension.
The predicted percentage methacrylation can then be
used for an optimal design of the NGC. For example,
when using TensorFlow platform to build a model to
predict the percentage methacrylation, we will need to
provide the model with a dataset including sample data
record in the following format: gap, time, diameter,
thickness, percentage methacrylation. The dataset can be
acquired from experiments. The more training samples,
the better the performance of the model is. However, in
data-limited situations, generative adversarial networks
(GANs) can be used to generate new sample data which
are realistic enough and proved to be really useful. The
dataset can split into a training and a test set. We can
use the training set to train the model and the test set
for the final evaluation of the model. The value range of
the gap, time, diameter and thickness can be different,
so normalization of these inputs can be conducted to
make the training easier. A sequential model can be used
with two densely connected hidden layers and an output
layer to predict a single value for percentage methacryla-
tion. The model can then be trained using the training
set and evaluated with the test set.
c. ML to optimize cell phenotype
Besides using ML to enhance NGC designs, it can be
used to optimize the biological components comprising
NGCs. Gene editing tools such as CRISPR-Cas9 work by
attaching protein Cas9 to a specific genetic target using
RNA guides. Effective gene editing requires selecting
RNA guides that are precise to the particular gene re-
gion of interest (on-target effects), while reducing the
RNA guide’s compatibility for other segments within the
genome (off-target effects). Machine Learning programs
have been developed to improve both on-target effi-
ciency (e.g. Azimuth) along and off-target prevention
(e.g. Elevation) using a regression tree with boosting
model [173]. Predictable and precise gene editing tools
can lend themselves to modifying cells to be more effect-
ive for nerve regeneration. This can occur by targeting
genes to increase the expression of Schwann cells, pro-
gramming nerves to differentiate as motor or sensory
nerves, enhancing immunomodulation of support cells,
or regulating the time of regenerative events. Another
research group, developed a novel method for making
template-free genome editing more precise using a ML
algorithm (e.g. inDelphi) to predict and design RNA
guides with preferred repair genotypes [174]. Training
data was acquired and the algorithm was refined to sep-
arate repair outcomes into deletions and insertions
based on their projected repair mechanisms [175]. The
mature program was able to correct over 183 pathogenic
human alleles in greater than half of the edited products,
designed predictable 1-base pair insertions, and en-
hanced success rates. Besides the use of ML for genetic
editing, ML can also make predictions about cell pheno-
types and gene-regulatory networks to further improve
cell selections incorporated into the end product [176].
Recent developments in stem cell technology have begun
to merge big data in the form of genomics, transcripto-
mics, proteomics, epigenomics, and metabolomics with
ML to safely produce cells that best match the target pa-
tient and the regenerative process of interest [177]. Stan-
dardized performance of stem cells will improve the
effectiveness of 3D bioprinted products and their
reproducibility.
d. ML for quantitative assessment of neuronal response
to NGC material properties and architecture
Quantitative assessment of neuronal response to the
surface topology is important [178, 179]. Advanced im-
aging and cellular image analysis can be used to object-
ively quantify both neuron and neurite outgrowth using
a number of measurements of neurons and neurites
[172, 179, 180]. The measurements include number of
neurons, total and average neurite outgrowth, total and
average neurite area, total and average number of seg-
ments, average branching layers, the longest neurite
from a neuron, total and average number of roots, total
and average number of extreme neurites, total and aver-
age number of branch points etc. The cellular image
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analysis can also help quantify the angle of neurite out-
growth, [181] number of axons, axonal growth and the
alignment of neurite [182]. Based on the measurements
on neuronal response, ML can help with the
optimization of surface characteristics. For examples,
studies show that topographical grooves with different
height and inter-groove spacing have different impacts
on neurite outgrowth. ML can help optimize these pa-
rameters for guiding neurite outgrowth [181]. Similar to
the example for the prediction of the percentage metha-
crylation, a ML model can be built to model the rela-
tionship between the neurite outgrowth, and the surface
topographies of NGC.
Nascent neurons elongate and elaborate fine and fra-
gile cellular extensions that form circuits enabling com-
munications and find paths to distant targets. As a result
of post-developmental neuronal damage, the cues for re-
innervation are no longer active. Advances in biomate-
rials are enabling fabrication of microenvironments that
encourage neuronal regrowth and restoration of function
by recreating these developmental cues. The combin-
ation of topographical and electrical cues greatly im-
proves length of neurite extension. Electrical stimulation
can be further integrated into the scaffold by choosing a
conductive base material. However, it is quite challen-
ging to manipulate and integrate these elements in dif-
ferent combinations to generate new technologies to
enhance neural repair. An ideal substrate for effective re-
pair should take into account the combination of topo-
graphical, chemical, electrical, and mechanical properties
of the substrate [183, 184]. Similar to the example for
the percentage methacrylation prediction, ML can be
used to optimize the engineering of the substrates by
identifying the optimal combination of topographical
and electrical cues.
e. Application to AM and 3DBP
Manufacturing three-dimensional (3D) structures in
nerve regeneration is a growing activity amongst tissue
engineers. Machine intelligence is beginning to
standardize AM methods in metal printing and more
rarely bioprinting. Bock et al. break down these ap-
proaches into descriptive, predictive, prescriptive cat-
egories for microstructure, process parameters,
mechanical properties, and performance in metal print-
ing [185]. Descriptive approaches explain how structural
patterns, material properties and printing processes re-
late to material performance. Descriptive tasks
emphasize pattern recognition and correlation to estab-
lish data-driven workflows in AM, which is currently
lacking in bioprinting [186]. Materials have microstruc-
tural properties that can be quantified in terms of size,
shape distribution, anisotropies, and component
geometries then analyzed using principal component
analysis, factor analysis, and independent component
analysis to discover techniques that reduce dimensional-
ity to extract process-structure linkages [186]. Thus, de-
scriptive approaches identify and validate input
(processes) leading to specific outputs (microstructural
patterns). Descriptive characterizations of microstruc-
tures remain a significant challenge in materials science.
Material informatics are beginning to develop objective
measures to distinguish between heterogenous materials
[186]. For instance, Altchuch et al. mined materials for
structural features based on pore size, pore shape, degree
of porosity to estimate the features of real membranes.
Finally, descriptive methods can be used to characterize
the effect of stress/strain (macroscale conditions) on
bone to compute mechanical property changes on tra-
becular bone at the mesoscale using finite element
stimulation and ANN [187, 188]. These techniques
could lend itself to electroconductive materials to im-
prove its biodegradability and elasticity.
Additionally, predictive approaches forecast the per-
formance of 3DBP products based on minute changes
made to microstructures, properties, or printing process.
Predictive approaches inform the engineer what param-
eter is most likely to produce a desired outcome. This
technique focuses and limits our tests to those with the
greatest likelihood of being significant, while minimizing
utilization of costly resources. Predictive tasks employ
ANNs to predict material properties (width, height,
strength, degradation rate, gf concentration, cell depos-
ition) from specific process parameters (print speed, ex-
trusion rate, temperature profile, nozzle-to-plate
distance, resistance to flow). Xiong et al. implemented a
similar ANN scheme for metal AM by relating process
parameters (welding speed, wire feed rate, arc voltage) to
height and weight of deposited layers [189]. Another in-
teresting study used a CNN architecture relating micro-
structural (lower-level) material information to
macroscale (higher-level) properties [190, 191]. This case
study found a 38% increase in predicting macroscale
strain component from microscale volume elements
compared to previous models [191]. When experimental
data is lacking, generative ML models can be used to
create authentic material samples to training purposes
[192].
Lastly, prescriptive approaches provide input recom-
mendations to produce certain outcomes. For example,
GF concentration should exceed this specified amount
(in ng or μg) to regenerate nerve across distance (in
mm). In this case, machine intelligence identifies which
process parameters should be applied to acquire a spe-
cific material property. Chupakhin et al. developed an
ANN to optimize residual stresses profiles in materials
after laser shock peening [193]. These strategies could
Stewart et al. Journal of Biological Engineering           (2020) 14:25 Page 11 of 19
be enlisted to propose specific processes and parameters
that attenuate the tension between material porosity and
biomaterial degradation and enhance nerve regeneration.
Prescriptive techniques could advise engineers the best
material properties for specific regenerative applications
by generating and refining random microstructure-
property pairs to select optimal results [191]. Liu et al.
took a ML-based approach to refine search paths and
decrease search regions when designing alloys [191].
This approach lowered costs for finding optimal solu-
tions. Similarly, a prescriptive framework used phase
field simulations to reduce the number of experiments
needed to establish process-structure-property linkages
[190].
Machine intelligence can also be used to improve bio-
printer performance. Researchers have used ANN to in-
vestigate orientation, the delay between layers, and layer
thickness as inputs in relation to porous structures and
scaffold strength as outputs [194]. The algorithm deter-
mined the optimal 3D fabrication parameter settings for
creating optimal porous structures for bone tissue regen-
eration. Gu et al. performed finite element analysis using
a ML algorithm to identify superior biomimetic micro-
structures focusing on material and geometric properties
[195, 196]. ML-based design created diverse microstruc-
tural patterns and materials that were proved effective
after 3D printing and testing. This research could extend
to nerve tissue engineering by optimizing microchannel
dimensions, arrangement, and conduit physical proper-
ties for regenerating sensory, motor, or mixed nerves.
Another ML algorithm called Non-dominated Sorting
teaching-learning-based optimization (NSTLBO) pro-
posed solutions to multi-objective optimization prob-
lems in rapid prototyping processes to minimize cost of
production with product quality, energy consumption,
and mechanical properties [197]. Similarly, other re-
search groups have augmented bioprinters using ML,
specifically to optimize their process parameters and im-
prove printer consistency [198–200]. Drop on demand
bioprinting must balance drop speed, drop volume, and
satellite generation [201]. Machine learning using the
Adam algorithm was found to improve printing preci-
sion and stability after training [201]. Tolerancing will
become a major issue for 3D bio-printed NGCs because
they contain multiple materials, biological components,
and geometric variation. Tolerancing refers to the con-
trol or limiting of geometric variation of the final prod-
uct. ML has helped limit variation for prints in AM and
provides another role in biofabrication standardization
[113]. Computer vision has been utilized in AM pro-
cesses to detect defects during the build process [202].
After proper training, the classifier was able to detect de-
fects with 80% accuracy. Machine sensors can analyze
acoustic signals or video recordings to assess the quality
of printed layers by identifying aberrant features [203,
204]. Machine vision can also fine-tune the electrohy-
drodynamic printing (EHDP) by monitoring cone shapes
for more precise scaffold biofabrication [205]. Digital
microscopic imaging combined with CNN Developing
automated inspection systems using machine
intelligence can reduce print variation experienced dur-
ing conduit production. Advancing ML in AM processes
is critical for scaling production, ensuring quality con-
trol, and minimizing cost-of-production in healthcare
settings [203].
f. Enhancing graft performance by neural networks
Matching a particular nerve graft to a patient is an im-
portant function that machine intelligence can perform
for PNI [206]. Many injuries may not require all of the
features mentioned in the previous sections, making
graft fabrication faster and cost-effective by tailoring fea-
tures for the particular patient and injury. Conforth
et al. developed a Swarm Intelligence based
reinforcement learning (SWIRL) to predict graft success
under specific conditions. SWIRL is an ANN that was
trained to identify the best combinations for a given out-
come [206]. Thirty variables were classified based on
biomaterials, ECM proteins, GFs, cells, number of lu-
mens, surface quality, and filling types. Outputs consid-
ered were regeneration length, ratio of actual length to
critical length, and graft success estimation. SWIRL was
able to obtain a greater than 92% accuracy for graft
selection.
Koch et al. used a calculated ratio of gap length di-
vided by the graft’s critical axon elongation as a measure
of nerve regenerative performance [207]. Bootstrap ag-
gregated neural networks were used to predict NGC per-
formance using 40 features as inputs. The selected
features included parameters known to impact the per-
formance of the conduits e.g. material process parame-
ters—phase separation and hydrogels, structural
parameters—internal diameter, conduit length, wall
thickness, and selected growth factors—NGF, NT3,
BDNF [207]. Experiments show that the bootstrap ag-
gregated neural networks outperform the SWIRL in
terms of prediction accuracy [207, 208]. The improved
accuracy can help engineers make more impactful design
decisions to optimize NGC performance.
g. Application of ML to regulatory compliance
FDA-approved devices for treating PNIs are typically
derived from natural biomaterials (collagen), synthetic
materials, or allogeneic tissue [62]. These devices fail to
repair nerve gaps exceeding 3 cm. This makes the devel-
opment of alternative devices desirable with customized
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material compositions using bioactive components [209,
210]. Advanced therapy medicinal products contain a
difficult burden of regulations to translate nerve con-
duits into clinical practice. Toxicity and biocompatibility
tests along with phase I and II trials are costly to per-
form. Current FDA device regulations will require over-
sight across multiple stages during manufacturing
including stem cell processing, device storage, and phar-
maceuticals. Product developers must consider product
shelf-life of 3D bio-printed conduits for
commercialization. Standardized manufacturing guide-
lines do not exist for NGC production. In general, there
is a requisite for FDA-approval to implement 3D bio-
printed devices on a clinical scale [211, 212]. Machine
intelligence can provide several useful tools to maintain
compliance with regulations to increase the likelihood of
devices reaching the testing stage. ML applications can
be developed to identify requirements and promote
compliance with regulations [213, 214]. One algorithm
works by matching regulatory requirements with engin-
eering processes to simplify product development, iden-
tify deviations from regulatory expectations, and
minimize administrative and fabrication costs [214].
Nomos3 is a modelling language specializing in model-
ling laws and regulations and performs automated com-
pliance analysis [214]. Another group tested three
different languages, namely, compliance request lan-
guage (CRL), computational tree logic (CTL), and linear
temporal logic (LTL) to maintain compliance with busi-
ness processes, operations, and practices [215]. Compli-
ance management frameworks inform businesses when
violations to rules have occurred and what solutions can
resolve violations [215, 216].
Conclusions and outlook
Peripheral nerve damage continues to have high inci-
dence in the United States, as well as poor prognosis
and lifelong disabilities. Due to the variety of peripheral
nerve damage etiologies, treating such condition by sur-
gical means remains a challenge. NGC provides an alter-
nate method to tradition surgical approaches such as
allogeneic nerve transfer, or in more extreme interven-
tions, free functional muscle transfer [217]. In this article
we have reviewed three categories of NGC design com-
ponents: biological modulation, engineering approaches
and surgical modulation. Furthermore, we examined
how machine intelligence can combine all three compo-
nents in NGC design and manufacturing with ML ap-
proaches. As depicted in Fig. 2, approaches discussed in
each section can be integrated to produce an NGC with
an optimal performance not only by design and engin-
eering perspectives, but by clinically applicable outcomes
to treat PNI. By doing so, we hope that soon personal-
ized NGC can be manufactured efficiently and effectively
with economy of scale.
As technology advances, personalized medicine in-
creases in demand and popularity [217]. Since each pa-
tient is different in metabolism and genetics, their
treatment response to biomaterials can differ signifi-
cantly. Effective NGC design requires the complex un-
derstanding of cellular machinery, tissue engineering
and surgical procedures, which requires a combined
team of scientists, engineers and physicians. Thus, such
designs incur high human cost and resources. It is more
efficient to use AI to generate quick, accurate and non-
bias design decisions, which can also constantly be
trained and developed by retraining the AI models on
Fig. 2 Hypothetical steps to create NGCs with the proposed integrated tissue engineering and machine intelligence approaches. The optimal
performance of NGC requires a tight integration and synergy from basic science, advanced tissue engineering approaches and clinical practices
with elaborated model of machine intelligence. Ample data will facilitate training and standardize the production and feedback look to fulfil the
requirement of regulatory compliance
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new data. As such, ML can advance the regeneration of
PNS in 3D biofabrication, graft performance and predic-
tion of NGC performance.
To achieve a quantum leap toward functional tissue
regeneration, we may have to look at the regeneration
problems at a different viewpoint. Although the field of
AI research was initiated at the Dartmouth Conference
in 1956, the power of AI was grossly underestimated,
followed by the AI winter. However, investment and
interest in AI has taken off since early 2010 when
ML showed meaningful progress to provide solutions
in academia and industry with significant advance-
ment in computing and storage hardware and the
presence of big data. The machine intelligence is be-
ing adopted to almost all areas. For example, biomed-
ical imaging [218] and electronic health record [219]
are already exploiting ML and AI. Now we want to
see the application of machine intelligence to a field
which is somewhat less systematically explored, or
traditionally more challenging, and is only dealt with
mathematical and statistical modeling.
One issue to consider with AI and ML is that they
require huge amount of training data sets to become
viable and reliable. The emergence of big data analyt-
ics allows extraction of relevant information from dif-
ferent research, data base and clinical data necessary
for ML. However, the ML models have been largely
attributed to the quality and diversity of training data.
If there is lack of such training data, data augmenta-
tion can be used to significantly increase the diversity
of data available for training models without actually
collecting new data. GAN can be used to generate
synthetic data for training ML models. However, deep
learning in biomedicine and 3D bioprinting is still in
its infancy, and that there is much to understand of
peripheral nerve regeneration biology. Furthermore,
ML designs must also be validated in an in vivo
model. As mentioned in the article, multiple groups
have attempted to utilize ML for optimization of
NGC designs, yet little have been done to test such
designs in an animal model. While ML models can
be used to predict the probability that such design
will optimize in peripheral nerve regeneration, clinical
trials in humans remains the gold standard for appli-
cation. There must be more in vivo studies using
such designs in mouse and monkeys as proof of con-
cept, so that ML generated NGCs can lead to clinical
trials.
We live in an exciting time where biological and
technological advancements emerge rapidly. For ex-
ample, CRISPR-Cas9 gene editing technology was dis-
covered in 2012, while GANS was invented in 2014
[218]. Given so many significant discoveries happen in
such a short amount of time, it is not hard to imagine
that AI and ML can also lead to great improvements in
NGC designs soon. In the future, there will be a much
heavier computational emphasis in drug and treatment
development [220], and that there will be horizontal in-
tegration between basic science, data science, engineer-
ing and clinical science. As deep learning develops it will
transform human wellness and healthcare.
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cells; UC-SC: Umbilical derived cells with stem cell properties
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